The GOLD International COPD Conference will cover underdiagnosis, exacerbations, mucus, biologics, and a preview of the 2027 GOLD Report.
|Articles|June 1, 2004
Supplements and Featured Publications
- Tabloid - Future Goals, Targets, and Treatments of Dyslipidemia
- Volume 10
- Issue 1 Treat
CME/CE Quiz
Advertisement
Articles in this issue
over 22 years ago
Dual pathway inhibition: Attacking cholesterol on two frontsover 22 years ago
Future Goals, Targets, and Treatments of Dyslipidemiaover 22 years ago
Managed Care Commentary:MCOs face new challengesover 22 years ago
Phytosterols may play role in atherosclerosisAdvertisement
Related to this article
People with multiple sclerosis make up most of a survey linking variable-friction footwear to fewer self-reported falls.
Clinicians at an AJMC roundtable in Cleveland said Medicare's GLP-1 Bridge came late and that cost and capacity gaps persist.
Nathan Estrada, DPT, explains which patients, including those with multiple sclerosis, may benefit from footwear that adapts to gait.
Patients with Sjögren disease have 5-fold higher odds of depression, yet screening tools remain unvalidated, a new review finds.
Medicare Advantage exits, rising ACA premiums, a Medicare for America bill, and a Medicaid work rule ruling frame health policy on Election Day.
Patient selection raised detection of pathogenic germline variants from 6% to 27% in lung cancer studies.
Pharmacists outline new oncologic therapeutics, from pancreatic cancer to myeloma, and what high prices and crowded markets mean for payers.
Advertisement
Advertisement
Trending on AJMC
1
First-Line Vitiligo Treatment: Topical JAK Inhibitors and Phototherapy
2
Unanswered Questions in First- and Second-Line mCRC Care
3
Cleveland Clinicians Say Obesity Care Starts Too Late for Many Patients
4
Precision Drugs Meet Payer Realities
5